May

Improvements in cancer treatment over the past few years have been exponential due to advances in cancer biomarker testing. Because of the rapidly growing field, it has been difficult for pathologists and clinicians to keep up with which tests should be used and how these results should be reported.

The new complimentary CAP Cancer Biomarker Reporting Templates for Breast, Colorectal and Lung Cancer, which are produced by the CAP Cancer Biomarker Reporting Committee, are now available on www.cap.org/cancerprotocols to help guide pathologists as to how to report results for commonly performed biomarker tests. These templates are based on available guidelines and expert panel opinion, determined by multidisciplinary panels representing several stakeholder organizations including CAP, AMP, ASCO, AJCC, NCCN and more.

Since many results from molecular testing may be available only after the rest of the pathology report is completed, these templates help guide the pathologist and facilitate testing result reporting in a standardized fashion.